Lurasidone HCl - A Long Term Safety Phase 3 Study of Patients With Clinically Stable Schizophrenia
Public ClinicalTrials.gov record NCT00641745. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Long-Term Safety, Tolerability, and Effectiveness of Lurasidone in Subjects With Schizophrenia or Schizoaffective Disorder: A Randomized, Active Comparator-Controlled Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Lurasidone HCl is a compound being developed for the treatment of schizophrenia. This clinical study is designed to test the hypothesis that lurasidone is safe and tolerable long term among clinically stable patients. The study will also assess the long term effectiveness of lurasidone as compared to an active comparator.
Study identification
- NCT ID
- NCT00641745
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 629 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2008 (Type not available)
- Primary completion
- Jul 2010 (Actual)
- Completion
- Jul 2010 (Actual)
- Last update posted
- Jun 22, 2015
2008 – 2010
United States locations
- U.S. sites
- 41
- U.S. states
- 18
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| K&S Professional Research Services LLC | Little Rock | Arkansas | 72201 | — |
| Woodland International Research Group, LLC | Little Rock | Arkansas | 72211 | — |
| South Coast Clinical Trials, Inc. | Anaheim | California | 92804 | — |
| Comprehensive NeuroScience, Inc. - Cerritos | Cerritos | California | 90703 | — |
| Clinical Innovations Inc. | Costa Mesa | California | 92626 | — |
| Collaborative Neuroscience Network Inc | Garden Grove | California | 92845 | — |
| University of Southern California | Los Angeles | California | 90033 | — |
| Excell Research | Oceanside | California | 92056 | — |
| University of California at Irvine Medical Center | Orange | California | 92868 | — |
| Pasadena Research Institute | Pasadena | California | 91107 | — |
| CNRI-Los Angeles, LLC | Pico Rivera | California | 90660 | — |
| Clinical Innovations Inc. | Riverside | California | 92506 | — |
| CNRI-San Diego LLC | San Diego | California | 92102 | — |
| UCSD, Outpatient Psychiatric Services | San Diego | California | 92103 | — |
| Clinical Innovations Inc. | Santa Ana | California | 92705 | — |
| Collaborative Neuroscience Network Inc | Torrance | California | 90502 | — |
| Comprehensive NeuroScience, Inc. | Washington D.C. | District of Columbia | 20016 | — |
| Fidelity Clinical Research Inc., c/o Segal Institute for Clinical Research | North Miami | Florida | 33161 | — |
| Fidelity Clinical Research Inc. | North Miami | Florida | 33161 | — |
| Atlanta Center for Medical Research | Atlanta | Georgia | 30308 | — |
| Northlake Medical Research Center | Tucker | Georgia | 30084 | — |
| Alexian Brothers Medical Center | Hoffman Estates | Illinois | 60169 | — |
| Lake Charles Clinical Trials | Lake Charles | Louisiana | 70601 | — |
| Sheppard Pratt Health System | Baltimore | Maryland | 21285 | — |
| Precise Research Center | Flowood | Mississippi | 39232 | — |
| St. Charles Psychiatric Associates - Midwest Research | Saint Charles | Missouri | 63301 | — |
| St. Louis Clinical Trials | St Louis | Missouri | 63118 | — |
| Creighton University | Omaha | Nebraska | 68131 | — |
| CRI Worldwide | Willingboro | New Jersey | 08046 | — |
| SUNY Downstate University | Brooklyn | New York | 11203 | — |
| Neurobehavioral Research Inc. | Cedarhurst | New York | 11516 | — |
| Manhattan Psychiatric Center | New York | New York | 10035 | — |
| Social Psychiatry Research Institute | New York | New York | 10454 | — |
| University of North Carolina at Chapel Hill | Raleigh | North Carolina | 27603 | — |
| Keystone Clinical Studies, LLC | Norristown | Pennsylvania | 19403 | — |
| CRI Worldwide | Philadelphia | Pennsylvania | 19139 | — |
| Research Strategies of Memphis LLC | Memphis | Tennessee | 38119 | — |
| Community Clinical Research, Inc. | Austin | Texas | 78754 | — |
| Pillar Clinical Research LLC | Dallas | Texas | 75243 | — |
| Claghorn-Lesem Research Clinic, Inc. | Houston | Texas | 77008 | — |
| Alliance Research Group | Richmond | Virginia | 23230 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 32 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00641745, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 22, 2015 · Synced Oct 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00641745 live on ClinicalTrials.gov.